Trial · NCT00550615
Adverse events260
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 260
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pleural effusion | Respiratory, thoracic and mediastinal disorders | Phase I Participants | 11 | 14 | 15 |
| other | Pleural effusion | Respiratory, thoracic and mediastinal disorders | Phase II Participants | 6 | 19 | 7 |
| other | platelet count decreased | Investigations | Phase I Participants | 6 | 14 | 6 |
| other | platelet count decreased | Investigations | Phase II Participants | 11 | 19 | 17 |
| other | anemia | Blood and lymphatic system disorders | Phase I Participants | 9 | 14 | 10 |
| other | anemia | Blood and lymphatic system disorders | Phase II Participants | 7 | 19 | 13 |
| other | Fatigue | General disorders | Phase I Participants | 6 | 14 | 7 |
| other | Fatigue | General disorders | Phase II Participants | 8 | 19 | 8 |
| other | diarrhea | Gastrointestinal disorders | Phase I Participants | 3 | 14 | 4 |
| other | diarrhea | Gastrointestinal disorders | Phase II Participants | 9 | 19 | 9 |
| other | Nausea | Gastrointestinal disorders | Phase I Participants | 5 | 14 | 6 |
| other | Nausea | Gastrointestinal disorders | Phase II Participants | 7 | 19 | 7 |
| other | White blood cell decreased | Investigations | Phase I Participants | 4 | 14 | 4 |
| other | White blood cell decreased | Investigations | Phase II Participants | 5 | 19 | 12 |
| other | Neutrophil count decreased | Investigations | Phase I Participants | 2 | 14 | 4 |
| other | Neutrophil count decreased | Investigations | Phase II Participants | 6 | 19 | 12 |
| other | vomiting | Gastrointestinal disorders | Phase I Participants | 5 | 14 | 5 |
| other | vomiting | Gastrointestinal disorders | Phase II Participants | 3 | 19 | 3 |
| other | fever | General disorders | Phase I Participants | 2 | 14 | 2 |
| other | fever | General disorders | Phase II Participants | 5 | 19 | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00550615/events